#### IV/PO model

Levetiracetam physiochemical properties and ADME parameters were incorporated from the model developed by Sinha, Karatza (25). **Table 1** presents the drug specific parameters of levetiracetam and the values used in the healthy adult IV model.

The healthy PBPK model development was based on single dose IV and oral PK studies described in Sinha, Karatza (25). These doses consisted of 500 mg, 1000 mg, and 2000 mg.

**Table 1. Physicochemical properties and ADME of caffeine for the final IV/PO model**

| **Physicochemical properties**    |                                      |
|--|--|
| Octanol:water coefficient (logP)           | -0.64 Log Units |
| Fraction unbound in plasma (f<sub>u</sub>) | 0.97 |
| Molecular weight (MW)                      | 170.21 g/mol |
| pKa                                        | Neutral |
| Water solubility                           | 1,040 mg/mL |
| **ADME**                                   |                             |
| Partition coefficient                      | Rodgers and Rowland |
| Cell permeability                          | PK-Sim Standard |
| RBC esterase concentration                 | 1 µM |
| RBC esterase K<sub>M</sub>                 | 439 µM |
| RBC esterase V<sub>max</sub>               | 8,000 pmol/min/mL |
| GFR fraction                               | 0.4 |
| Specific intestinal permeability (transcellular) | 1.84E-3 cm/min |
| **Oral absorption parameters**             |                             |
| Formulation: Tablet T<sub>50%</sub>, T<sub>90%</sub>, T<sub>100%</sub> | 5 min, 10 min, 15 min |
T<sub>50%</sub>, T<sub>90%</sub>, T<sub>100%</sub>: Time to disolve 50%, 90%, and 100% tablet strength, respectively (25).